My Photo
Blog powered by Typepad

Powered by Rollyo

Blogroll Library Search

« China and India Patent Law Panel | Main | ITC Commission Issues Favorable Ruling in Kodak Patent Case Against Apple and RIM »


pharma feedback

The US Court of Appeals for the Federal Circuit has overturned a prior ruling by the US District Court for the District of New Jersey and upheld the validity of Eli Lilly's method-of-use patent on the attention deficit hyperactivity disorder drug, Strattera (atomoxetine). In the case of Lilly versus Actavis Elizabeth L.L.C. et al, the Court ruled in favour of Lilly, upholding the method-of-use patent, which provides protection for Strattera through May 2017.

pharma reviews

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

The comments to this entry are closed.